Hendrik Knoetgen

This inventor holds 15 USPTO granted patents and 17 published patent applications, plus 5 CIPO patents and 10 EPO patents. Top assignees: Hoffmann-La Roche Inc., Roche Palo Alto LLC. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hendrik Knoetgen. Retrieved from https://idiyas.com/inventor/hendrik-knoetgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 17)

% Patents Active = 40.0

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 19)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 98(Granted Patents)

Company Filing History:

14 out of 5,024

Hoffmann-La Roche Inc.

Years Active: 2009-2021

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10882910 - Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides (2021-01-05),

2. 10501521 - Disulfide-linked multivalent MHC class I comprising multi-function proteins (2019-12-10),

3. 9963511 - Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides (2018-05-08),

4. 9428766 - Protein expression from multiple nucleic acids (2016-08-30),

5. 9187564 - Antibodies against human TWEAK and uses thereof (2015-11-17),

6. 8883976 - Antibodies against human tweak and uses thereof (2014-11-11),

7. 8852887 - Antibodies against human tweak and uses thereof (2014-10-07),

8. 8771988 - Protein expression from multiple nucleic acids (2014-07-08),

9. 8552158 - Method for the production of insulin-like growth factor-1 (2013-10-08),

10. 8476232 - Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) (2013-07-02),

11. 8314225 - Heavy chain mutant leading to improved immunoglobulin production (2012-11-20),

12. 8207307 - Antibodies against human CCN1 and uses thereof (2012-06-26),

13. 8093006 - Antibodies against human tweak and uses thereof (2012-01-10),

14. 8003099 - Antibodies against human IL17 and uses thereof (2011-08-23),

15. 7625996 - Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) (2009-12-01),

Title: Hendrik Knoetgen - Innovative Inventor from Penzberg

Introduction: Hendrik Knoetgen is a renowned inventor hailing from Penzberg, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Hendrik Knoetgen holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Knoetgen has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Hendrik Knoetgen has collaborated with top companies, innovative startups, and talented individuals to bring his inventions to life and make a lasting impact on society.

Conclusion: Hendrik Knoetgen's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring the next generation of inventors.

Profile summary based on public USPTO records.